The global deep brain stimulation devices market was valued at US$ 664.4 million in 2015 and is expected to expand at a CAGR of 8.2% during the forecast period - 2024
Oxygen therapy is the use of oxygen as medical intervention to maintain enough oxygen in conditions such as hypoxia, hypoxemia, and other related conditions.
The technology offers better clinical examinations compared to petri dishes and animal testing – helping scientists and companies to better understand the functioning of internal organs such as the brain and lungs.
The Pharmacy Benefit Management Market is Highly Concentrated in Developed Markets and The providers of pharmacy benefit management services also manage the prescription drug claims i.e.
Psoriasis is a non-communicable autoimmune disease characterized by patches of abnormal skin. These skin spots are red, itchy, and scaly which may be small and localized or cover the entire body.
The major players in the customized gene therapy treatments for cancer market include Amgen, Inc., SynerGene Therapeutics, Inc., Chengdu Shi Endor Biological Engineering Technology Co., Ltd., Cold Genesys, Inc., Takara Bio, Inc.,
The influx of non-invasive therapy has reinforced the diabetes market in various ways ranging from economical cost incurred to patient treatment outcomes.
The production of intrauterine contraceptive devices include Bayer HealthCare AG, Melbea AG, DKT International, Medicines360 and Egemen International among .
The heavy power surgical tools are Stryker, Boston Medical, Roche, DePuy Synthes, Medtronic Inc., and Zimmer Biomet, etc. The industry is highly consolidated.
Some key players engaged in the market are Aspect Biosystems, BioBots TeVido, Organovo, Cyfuse Biomedical, 3Dynamics Systems, Luxexcel Group, Stratasys, and Envision TEC.